Go to the mobile version of this Web site.

Login | Contact Us | Site Map | Paid archives | Alerts | Electronic edition | Advertise | Subscribe to the paper | Today's Extras
Subscribe

Pharmion deal gets OK from proxy firms

Published February 27, 2008 at 12:05 a.m.

Text size  

Pharmion, based in Boulder, says that all four major proxy-advisory services have recommended shareholders vote in favor of its merger with Celgene.

"We are pleased that ISS, as well as the other leading independent proxy advisory firms - Glass Lewis & Co., PROXY Governance and Egan-Jones Proxy Services - have all recognized the strategic and economic logic of our merger with Celgene," said Patrick Mahaffy, Pharmion's president and chief executive officer.

The deal comes to a vote March 6.

Post your comment

Registration is required. Click here to create your free user account, or login below.

Comments are the sole responsibility of the person posting them. You agree not to post comments that are off topic, defamatory, obscene, abusive, threatening or an invasion of privacy. Violators may be banned. Click here for our full user agreement.




(Forgotten your password?)




News Tip

Know about something we should be reporting? Tell us about it.


Reprints